Karen Ebsworth

Scientist I / Scientist II at Chemocentryx

Karen Ebsworth's Professional Contact Details

Email (Verified)

****@chemocentryx.com

Get Email Address

(650) 210-2900

Location

San Francisco, California, US

Company

Chemocentryx

Person Seniority

entry

Karen Ebsworth's Current Company Details

Chemocentryx

• 40 Employees

biotechnology

ChemoCentryx, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer primarily focused on orphan and rare diseases. ChemoCentryx is the only company focused exclusively on small molecule therapeutics that target the chemoattractant system, a biological network that regulates inflammation via a collection of secreted chemokine molecules, or ligands, and their specific cell surface receptors. ChemoCentryx has generated a broad portfolio of clinical and preclinical-stage programs, each targeting distinct chemokine and chemoattractant receptors. We are passionate about the science underlying the chemoattractant network and about the opportunity it holds to provide better medicines for better lives.

Public Symbol

CCXI

Founded Year

1997

Organization Website

chemocentryx.com

Organization Languages

English

Organization Revenue

11900

Current Technologies

dyn managed dns